Claro Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$605K Sell
2,547
-43
-2% -$8.94K 0.06% 236
2026
Q1
$547K Buy
+2,590
New +$558K 0.07% 224
2023
Q4
Sell
-3,037
Closed -$264K 390
2023
Q3
$264K Buy
+3,037
New +$275K 0.07% 292
2021
Q4
Sell
-10,393
Closed -$514K 287
2021
Q3
$514K Buy
10,393
+1,777
+21% +$96.4K 0.22% 135
2021
Q2
$492K Buy
8,616
+107
+1% +$6.25K 0.22% 128
2021
Q1
$517K Buy
8,509
+71
+0.8% +$3.92K 0.26% 111
2020
Q4
$452K Sell
8,438
-78
-0.9% -$4.05K 0.24% 117
2020
Q3
$400K Buy
8,516
+78
+0.9% +$4K 0.25% 114
2020
Q2
$440K Buy
8,438
+56
+0.7% +$2.89K 0.3% 97
2020
Q1
$402K Buy
8,382
+106
+1% +$5.5K 0.37% 83
2019
Q4
$419K Buy
8,276
+79
+1% +$4.08K 0.32% 87
2019
Q3
$387K Buy
8,197
+41
+0.5% +$1.87K 0.34% 86
2019
Q2
$384K Buy
8,156
+114
+1% +$5.26K 0.35% 87
2019
Q1
$387K Buy
8,042
+110
+1% +$5.51K 0.38% 82
2018
Q4
$428K Buy
+7,932
New +$413K 0.34% 67

Other funds holding CAH

Claro Advisors's CAH Position: Q2 2026 in Review

Claro Advisors reduced its Cardinal Health (CAH) stake by 1.7% in Q2 2026, selling an estimated $8.94K and leaving 2,547 shares worth $605K. The position accounts for 0.06% of the portfolio, ranked #236.

Claro Advisors first reported a position in CAH in Q4 2018 and has held it in 15 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Claro Advisors held 2,547 shares of Cardinal Health worth $605K as of Q2 2026.
  • Claro Advisors sold 43 Cardinal Health shares in Q2 2026, an estimated $8.94K.
  • Cardinal Health made up 0.06% of Claro Advisors's portfolio in Q2 2026, its #236 holding.
  • Claro Advisors first reported a position in Cardinal Health in Q4 2018 and has held it in 15 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Claro Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.